| Literature DB >> 28436320 |
Domenico Schillaci1, Maria Grazia Cusimano1, Stella Maria Cascioferro1, Vita Di Stefano1, Vincenzo Arizza2, Marco Chiaramonte1, Luigi Inguglia2, Abdulhakim Bawadekji3, Salvatore Davino4, Maria Letizia Gargano5, Giuseppe Venturella5.
Abstract
Medicinal mushrooms represent an unlimited source of polysaccharides with nutritional, antitumoral, antibacterial, and immune-stimulating properties. Traditional studies of epigeous higher Basidiomycetes have recently been joined by studies of hypogeous fungi and, in particular, of so-called desert truffles. With the aim to obtain novel agents against bacteria of clinical importance, we focused on the edible desert truffle mushrooms Tirmania pinoyi, Terfezia claveryi, and Picoa juniperi as sources of new antimicrobial agents. In particular, we investigated the in vitro antibacterial activity of acid-soluble protein extracts (aqueous extracts) of these 3 species against the Gram-positive human pathogenic reference strain Staphylococcus aureus ATCC 29213 and the Gram-negative strain Pseudomonas aeruginosa ATCC 15442. The acid-soluble protein extracts of T. pinoyi and T. claveryi showed minimum inhibitory concentrations of 50 μg/mL against tested pathogens. We believe that such preliminary results are promising to obtain a valuable antibiotic alternative to fight antibiotic-resistant pathogens.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28436320 DOI: 10.1615/IntJMedMushrooms.v19.i2.30
Source DB: PubMed Journal: Int J Med Mushrooms ISSN: 1940-4344 Impact factor: 1.921